These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Analysis of pregnancy outcomes of polycystic ovary syndrome patients after frozen embryo transfer].
    Author: Lyu XD, Qiao J.
    Journal: Zhonghua Fu Chan Ke Za Zhi; 2018 Jan 25; 53(1):31-34. PubMed ID: 29374883.
    Abstract:
    Objective: To investigate pregnancy outcomes of the patients with polycystic ovary syndrome (PCOS) after frozen embryo transfer (FET) . Methods: Data of 2 367 PCOS patients received in vitro fertilization-embryo transfer [including fresh embryo transfer (fET) and FET] from January 2009 to December 2015 in Peking University Third Hospital were evaluated retrospectively. The basal characteristics, pregnancy complications and outcomes were analyzed, then identified the relative factors followed. Results: Totally 2 367 patients received in vitro fertilization-embryo transfer: 1 106 were treated with fET, and the rest 1 261 cases were treated with FET. The incidence of gestational diabetes mellitus (GDM) was lower in FET group [4.04%(51/1 261) versus 6.15%(68/1 106)], the difference was statistically significant (P<0.05). Singletons born after FET had higher birth weight than fET [(3 406±548) versus (3 360±533) g], the difference was statistically significant (P<0.05). There was no difference of other pregnancy complications between the two groups (all P>0.05). fET was an independent risk factor for GDM (adjusted OR=1.570, 95%CI: 1.075-2.294). Conclusion: Compared with fET, FET could decrease the risk of GDM and receive better neonatal outcomes in patients with PCOS. 目的: 探讨解冻周期胚胎移植对多囊卵巢综合征(PCOS)患者妊娠结局的影响。 方法: 对2009年1月至2015年12月在北京大学第三医院行体外受精-胚胎移植治疗后获得单胎妊娠、并于孕28周后分娩的PCOS患者共2 367例,胚胎移植分为新鲜周期移植(1 106例)和解冻周期移植(1 261例)。收集并分析患者的孕前、妊娠期及分娩期的相关临床资料。 结果: 解冻周期移植的PCOS患者妊娠期糖尿病(GDM)的发生率显著低于新鲜周期移植者,分别为4.04%(51/1 261)、6.15%(68/1 106),两者比较,差异有统计学意义(P<0.05)。解冻周期移植的PCOS患者分娩孕周及新生儿出生体质量均显著大于新鲜周期移植者,分别为(38.8±2.0)、(38.4±1.9)周及(3 406±548)、(3 360±533)g,分别比较,差异均有统计学意义(P均<0.05)。其他产科并发症比较,差异均无统计学意义(P均>0.05)。新鲜周期移植是GDM的高危因素(校正OR=1.570,95%CI为1.075~2.294)。 结论: 解冻周期胚胎移植可能减少PCOS患者发生GDM,改善新生儿结局。.
    [Abstract] [Full Text] [Related] [New Search]